3 July 2026
Helios Underwriting plc
('Helios' or 'the Company')
Results of Scrip Dividend Election
Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, announces that it has received elections to receive the final dividend for the year ended 31 December 2025 in the form of a Scrip Dividend from shareholdings totalling 17,638,377 ordinary shares. This represents 25.45% of the total shares currently in issue (excluding 5,911,833 ordinary shares which are held in treasury). 823,838 new ordinary shares will be issued in lieu of a cash dividend payable.
The payment of the dividend and issue of shares pursuant to the Scrip Dividend was approved at the Company's Annual General Meeting ('AGM') on Monday, 22 June 2026.
The dividend is due to be paid on Friday, 10 July 2026. Admission of the new shares is expected to occur on the same date.
For further information, please contact:
Helios Underwriting plc
Louis Tucker - Chief Executive Officer +44 (0)20 3965 6441
Adhiraj Maitra - Director of Finance and Operations +44 (0)20 3743 2114
Peel Hunt (Nomad, Broker and Financial Adviser)
Dan Webster / Andrew Buchanan / Martin Frowde +44 (0)20 7418 8900
Singer Capital Markets (Joint Broker)
Charles Leigh-Pemberton / Russell Cook / James Todd +44 (0)20 7496 3000
FTI Consulting
Ed Berry +44 (0)7703 330 199
Christian Harte +44 (0)7974 288 763
About Helios
Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DIVSSASMDEMSESW